Combined Erlotinib and PF ‐03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma
Cell Proliferation, EarlyView.
Source: Cell Proliferation - Category: Cytology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cytology | HNSCC | Skin Cancer | Squamous Cell Carcinoma | Tarceva